243 related articles for article (PubMed ID: 23042785)
1. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.
Szemes M; Dallosso AR; Melegh Z; Curry T; Li Y; Rivers C; Uney J; Mägdefrau AS; Schwiderski K; Park JH; Brown KW; Shandilya J; Roberts SG; Malik K
Hum Mol Genet; 2013 Jan; 22(1):74-83. PubMed ID: 23042785
[TBL] [Abstract][Full Text] [Related]
2. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
[TBL] [Abstract][Full Text] [Related]
3. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.
Hancock AL; Brown KW; Moorwood K; Moon H; Holmgren C; Mardikar SH; Dallosso AR; Klenova E; Loukinov D; Ohlsson R; Lobanenkov VV; Malik K
Hum Mol Genet; 2007 Feb; 16(3):343-54. PubMed ID: 17210670
[TBL] [Abstract][Full Text] [Related]
4. Clonal Cytopenia of Undetermined Significance in a Patient with Congenital Wilms' Tumor 1 and Acquired DNMT3A Gene Mutations.
Murakami K; Yamaguchi Y; Kida Y; Morikawa Y; Ujiie H; Sugahara H; Nannya Y; Ogawa S; Kanakura Y
Intern Med; 2021 Dec; 60(23):3785-3788. PubMed ID: 34053991
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
Wagner KJ; Roberts SG
Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
[TBL] [Abstract][Full Text] [Related]
6. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
7. Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.
Lai YC; Lu MY; Wang WC; Hou TC; Kuo CY
Int J Exp Pathol; 2022 Jun; 103(3):121-128. PubMed ID: 35436013
[TBL] [Abstract][Full Text] [Related]
8. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
[TBL] [Abstract][Full Text] [Related]
9. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer.
Wagner KJ; Cooper WN; Grundy RG; Caldwell G; Jones C; Wadey RB; Morton D; Schofield PN; Reik W; Latif F; Maher ER
Oncogene; 2002 Oct; 21(47):7277-82. PubMed ID: 12370819
[TBL] [Abstract][Full Text] [Related]
10. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
Morrison DJ; English MA; Licht JD
Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
[TBL] [Abstract][Full Text] [Related]
11. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
13. In silico regulatory analysis for exploring human disease progression.
Holloway DT; Kon M; DeLisi C
Biol Direct; 2008 Jun; 3():24. PubMed ID: 18564415
[TBL] [Abstract][Full Text] [Related]
14. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
15. Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours.
Mares J; Kríz V; Weinhäusel A; Vodicková S; Kodet R; Haas OA; Sedlácek Z; Goetz P
Cancer Lett; 2001 May; 166(2):165-71. PubMed ID: 11311489
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter.
Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF
J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626
[TBL] [Abstract][Full Text] [Related]
17. Ectopic DNMT3L triggers assembly of a repressive complex for retroviral silencing in somatic cells.
Kao TH; Liao HF; Wolf D; Tai KY; Chuang CY; Lee HS; Kuo HC; Hata K; Zhang X; Cheng X; Goff SP; Ooi SK; Bestor TH; Lin SP
J Virol; 2014 Sep; 88(18):10680-95. PubMed ID: 24991018
[TBL] [Abstract][Full Text] [Related]
18. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes.
Wu H; Coskun V; Tao J; Xie W; Ge W; Yoshikawa K; Li E; Zhang Y; Sun YE
Science; 2010 Jul; 329(5990):444-8. PubMed ID: 20651149
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes.
Hamatani H; Sakairi T; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
Nephrology (Carlton); 2019 May; 24(5):575-584. PubMed ID: 29851165
[TBL] [Abstract][Full Text] [Related]
20. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells.
Gu T; Lin X; Cullen SM; Luo M; Jeong M; Estecio M; Shen J; Hardikar S; Sun D; Su J; Rux D; Guzman A; Lee M; Qi LS; Chen JJ; Kyba M; Huang Y; Chen T; Li W; Goodell MA
Genome Biol; 2018 Jul; 19(1):88. PubMed ID: 30001199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
